| First Author | Murphy ML | Year | 2001 |
| Journal | Eur J Immunol | Volume | 31 |
| Issue | 10 | Pages | 2848-56 |
| PubMed ID | 11592059 | Mgi Jnum | J:72355 |
| Mgi Id | MGI:2152501 | Doi | 10.1002/1521-4141(2001010)31:10<2848::aid-immu2848>3.0.co;2-t |
| Citation | Murphy ML, et al. (2001) IL-10 mediates susceptibility to Leishmania donovani infection. Eur J Immunol 31(10):2848-56 |
| abstractText | Human visceral leishmaniasis (VL) results in a severe and potentially fatal systemic disease, accompanied by cellular immune depression. The production of IL-10 correlates with ongoing diseaseand it has been suggested that the cellular immune depression that accompanies active disease may be due to a predominance of IL-10 production rather than a lack of IFN-gamma production, which is essential for optimal macrophage activation and parasite elimination. To examine the role of IL-10 in resistance during L. donovani infection (a causative agent of VL), the course of infection was examined in mice lacking the gene for IL-10. BALB/c IL-10(-/-), as well as C57BL/6 IL-10(-/-) mice, were highly resistant to L. donovani infection, asevidenced by liver parasite burdens which were tenfold lower than those in control mice after 14 days of infection. Enhanced resistance was accompanied by increased production of IFN-gamma and nitric oxide in BALB/c IL-10(-/-) mice. Susceptibility to infection in BALB/c IL-10(-/-) mice was enhanced following in vivo treatment with a neutralizing antibody to IFN-gamma or IL-12. Together these studies demonstrate for the first time that IL-10 is a critical component of the immune response that inhibits resistance to L. donovani. |
